Liposomal Cetirizine
N/A
Report date: 2026/03/30 17:02:26
Base Information
Drug NameLiposomal Cetirizine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNicox
China Registration ClassN/A
Develop Information
Active CompaniesSouth Valley University
Inactive CompaniesBiolipox Ab
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksWikipedia